NovoCare
Status: Verified · 2 row(s) on file · checked 2026-09-17
A data file, not a finished review: the prices below are first-party captures from the provider’s own live pages, with intro/renewal, membership, and offer conditions stored on each row with their source and check date. Each figure was read on NovoCare’s own pages on the date shown; a verified figure expires after 90 days and is rechecked, and any condition attached to a price (a promotion, a prepaid term, a refund rule) is recorded on the row.
First-party verified pricing on file · semaglutide
- Semaglutide (brand_pen)
- from $349/mo — month-to-month; calendar-month billing; $0 membership
- Semaglutide (brand_oral)
- from $149/mo — month-to-month; calendar-month billing; $0 membership
- Provenance
- novocare.com · checked 2026-09-17
Provider scorecard — the fields the sprint fills
| Pharmacy on file | not yet on file — queued |
| Pharmacy type | queued |
| States served | queued — unconfirmed coverage keeps state pages noindexed |
| Membership · consult fee | $0 · $0 |
| Dose-change policy | not stated |
| Cancellation terms | queued |
| Shipping | queued |
| Intro price (first month/period) | — |
| Medication included in price | yes |
| Offer conditions on file | — |
| Offer expiry / scheduled recheck | — |
| Support-response test | pending — standardized three-question timed email test, per the sprint |
| Cancellation walkthrough | pending — scripted cancel-and-document test, per the sprint |
| Update history | row verified/recorded 2026-09-17 · file regenerated 2026-09-20 |
Watch-outs recorded by trackers
- Wegovy self-pay offer page read 2026-09-17: new patients pay '$199 for each month of 0.25 mg & 0.5 mg' for two monthly fills through 2026-12-31, then '$349 per month' for the standard doses and '$399 per month for Wegovy HD 7.2 mg'; self-pay through NovoCare Pharmacy; patients in government programs may pay the self-pay price.
- Wegovy self-pay offer page read 2026-09-17: the Wegovy pill is '$149 for each month of 1.5 mg, $199 per month for 4 mg and $299 per month for 9 mg and 25 mg' through NovoCare Pharmacy; no effective date printed on the page.
What we have not verified
The standing (non-promo) rate at every dose; whether the figure is all-inclusive; the dispensing pharmacy and its 503A/503B status; state availability; cancellation terms. Until those are recorded first-party, NovoCare appears in ranked tables at its reported figure with a Reported chip, never a Verified one — the same rule applied to every program here, including every partner program — placements are labeled “Editor’s Pick” and disclosed.
No outbound link: we have not confirmed this program's canonical domain first-party, and we do not guess URLs.